E09.3592 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy without macular edema, left eye

Name of the Condition

• Drug or Chemical Induced Diabetes Mellitus with Proliferative Diabetic Retinopathy Without Macular Edema, Left Eye (ICD-10 Code: E09.3592)

Summary

Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy without macular edema, left eye is a condition where elevated blood sugar levels, caused by exposure to specific medications or chemicals, lead to advanced eye complications. This form of diabetes is directly attributable to external factors that disrupt glucose metabolism, resulting in hyperglycemia and associated retinal damage. Proliferative diabetic retinopathy is characterized by abnormal blood vessel growth in the retina, which can threaten vision, while the absence of macular edema indicates no swelling in the macula. The left eye is specifically affected in this case.

Causes

The condition is caused by exposure to drugs or chemicals that impair glucose regulation, leading to uncontrolled hyperglycemia. Common culprits include medications (e.g., glucocorticoids, antipsychotics, or diuretics) and toxins that reduce insulin secretion or increase insulin resistance. These substances trigger hyperglycemia, which, if untreated, progresses to proliferative diabetic retinopathy due to damage to blood vessels in the retina. The left eye involvement is a specific anatomical detail of the condition.

Risk Factors

• Use of medications known to affect glucose metabolism (e.g., steroids, antiretrovirals).
• Exposure to chemicals or toxins that disrupt endocrine function.
• Pre-existing metabolic conditions that increase susceptibility to drug-induced effects.
• Prolonged or high-dose exposure to glucose-altering substances.
• History of diabetes or retinal disease.

Symptoms

• Blurred or distorted vision in the left eye.
• Floaters or spots in the visual field.
• Difficulty seeing in low light.
• Sudden vision loss (in severe cases).
• Eye pain or redness (less common).

Diagnosis

Diagnosis involves a combination of clinical evaluation, medical history, and diagnostic tests. A healthcare provider will assess symptoms, review medication or chemical exposure, and perform an eye examination, including dilated retinal imaging (e.g., fundus photography or optical coherence tomography). Blood tests to measure glucose levels and hemoglobin A1c may confirm diabetes. Retinal imaging helps identify proliferative changes and rule out macular edema. The left eye is specifically examined to confirm involvement.

Treatment Options

Treatment focuses on managing blood sugar levels and addressing retinal complications. This may include discontinuing the causative drug or chemical, if possible, and initiating glucose-lowering therapies (e.g., insulin or oral medications). For retinopathy, laser therapy or anti-VEGF injections may be used to reduce abnormal blood vessel growth. Regular eye monitoring is essential to track progression and adjust treatment.

Prognosis and Follow-Up

Prognosis depends on early detection and management of both diabetes and retinopathy. With proper glucose control and timely retinal treatment, vision loss can often be prevented or minimized. Follow-up care includes regular eye exams (every 3–6 months) and ongoing monitoring of blood sugar levels. Long-term management is necessary to reduce the risk of further complications.

Complications

• Permanent vision loss in the left eye.
• Retinal detachment.
• Glaucoma.
• Increased risk of other diabetes-related complications (e.g., kidney or nerve damage).

Lifestyle & Prevention

• Avoid or limit exposure to known glucose-altering medications or chemicals.
• Maintain a healthy diet and exercise routine to support metabolic health.
• Monitor blood sugar levels regularly if at risk.
• Attend routine eye exams, especially if diabetes is present.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden vision changes, increased floaters, or eye pain in the left eye. Regular check-ups are recommended for those with a history of drug-induced diabetes or retinal disease.

Tips for Medical Coders

Document the specific eye involvement (left eye) and confirm the absence of macular edema. Ensure the causative drug or chemical exposure is clearly recorded, as this supports the diagnosis. Verify that the code E09.3592 is used only when proliferative diabetic retinopathy without macular edema is present in the left eye, with no other eye involvement specified.